L26/P-812 Links between environmental per- and polyfluoroalkyl substances and polycystic ovary syndrome: evidence from a non-infertile population and murine model
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C.C. Huang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do environmental per- and polyfluoroalkyl substance (PFAS) exposures and phenotypic associations differ between non-infertile women with polycystic ovary syndrome and controls, and in murine models? Summary answer PFAS exposure is significantly higher in non-infertile women with polycystic ovary syndrome, correlates with insulin resistance and hyperandrogenism, and induces polycystic ovarian morphology in mice. What is known already Although previous literature suggests strong links between endocrine-disrupting chemicals (EDCs) and polycystic ovary syndrome (PCOS), most studies have focused on non-persistent EDCs such as bisphenol A. In contrast, the role of persistent EDCs, including PFAS, in PCOS remains less well understood. PFAS are bioaccumulative pollutants with long biological half-lives and widespread human exposure. Most epidemiological studies have been conducted in infertility clinic populations, comparing infertile women with and without PCOS. As infertility itself may be associated with environmental exposure and altered endocrine profiles, such designs raise concerns regarding selection bias and limit generalisability to the general population. Study design, size, duration This pilot case–control study included 20 non-infertile women with phenotype A PCOS and 17 non-infertile controls recruited from a tertiary medical centre between July 2021 and February 2023. Parallel murine experiments (n = 4 per group) were conducted to explore the histological effects of PFAS exposure on the ovaries and uterus. Participants/materials, setting, methods Serum concentrations of twelve PFAS were quantified using Ostro™ solid-phase extraction coupled with ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS). Female mice aged 6–7 weeks were randomised into four groups (n = 4/group): control, vehicle (corn oil), low-dose PFOS (1 mg/kg/day), and high-dose PFOS (10 mg/kg/day). PFOS was administered by oral gavage for three weeks, followed by ovarian and uterine histological analyses. Main results and the role of chance Mean age (28.3 ± 4.0 vs 30.5 ± 4.9 years) and BMI (22.3 ± 3.9 vs 21.4 ± 2.5 kg/m²) were comparable between PCOS and control groups. All PCOS participants exhibited phenotype A and had significantly higher serum AMH, LH, total testosterone, and free androgen index (FAI) than controls. Among the twelve PFAS analysed, women with PCOS showed significantly higher serum perfluorobutanoic acid (PFBA) concentrations (3.91 ± 0.70 vs 3.42 ± 0.56 ng/mL, p = 0.0257) and trends toward higher PFOS, PFPeA, PFHxA, and PFHxS levels, although these did not reach statistical significance, likely due to limited sample size. Correlation analyses demonstrated significant positive associations between several PFAS and ovarian volume and AMH levels. PFBA levels also showed trends toward positive correlations with the homeostatic model assessment for insulin resistance (r = 0.31, p = 0.058) and FAI (r = 0.29, p = 0.083). In murine experiments, high-dose PFOS exposure (10 mg/kg/day) resulted in significantly increased tertiary follicle density compared with vehicle controls (9.0 vs 5.2 follicles/mm², p = 0.0397), consistent with antral follicle accumulation and polycystic ovarian morphology, indicating ovulatory dysfunction and follicular arrest. High-dose PFOS exposure was also associated with uterine epithelial thinning and compact stromal architecture. Limitations, reasons for caution This pilot study is limited by small sample size and an exploratory design. Larger human cohorts are needed. Preliminary animal experiments were designed for feasibility and dose exploration, and further mechanistic studies are required. Wider implications of the findings By avoiding infertility-related selection bias, this study provides evidence from a non-infertile population linking PFAS exposure to PCOS. The findings support persistent EDCs as potential upstream contributors to female reproductive disorders and justify larger population-based and mechanistic investigations. Trial registration number No
Zitieren
APA
Huang, C., & Yang, J. (2026). L26/P-812 Links between environmental per- and polyfluoroalkyl substances and polycystic ovary syndrome: evidence from a non-infertile population and murine model. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1139
Vancouver
Huang C, Yang J. L26/P-812 Links between environmental per- and polyfluoroalkyl substances and polycystic ovary syndrome: evidence from a non-infertile population and murine model. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1139
BibTeX
@article{Huang2026,
author = {Huang, C.C. and Yang, J.H.},
title = {L26/P-812 Links between environmental per- and polyfluoroalkyl substances and polycystic ovary syndrome: evidence from a non-infertile population and murine model},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1139}
}
EUVIMED